Aberrant expression of CPSF1 promotes head and neck squamous cell carcinoma via regulating alternative splicing.
Alternative mRNA splicing increases protein diversity, and alternative splicing events (ASEs) drive oncogenesis in multiple tumor types. However, the driving alterations that underlie the broad dysregulation of ASEs are incompletely defined. Using head and neck squamous cell carcinoma (HNSCC) as a m...
Main Authors: | Akihiro Sakai, Mizuo Ando, Takahito Fukusumi, Shuling Ren, Chao Liu, Jesse Qualliotine, Sunny Haft, Sayed Sadat, Yuki Saito, Theresa W Guo, Guorong Xu, Roman Sasik, Kathleen M Fisch, J Silvio Gutkind, Elana J Fertig, Alfredo A Molinolo, Joseph A Califano |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0233380 |
Similar Items
-
Molecular details of the CPSF73-CPSF100 C-terminal heterodimer and interaction with Symplekin
by: Stéphane Thore, et al.
Published: (2023-11-01) -
OutSplice: A Novel Tool for the Identification of Tumor-Specific Alternative Splicing Events
by: Joseph Bendik, et al.
Published: (2023-10-01) -
CPSF3 Promotes Pre-mRNA Splicing and Prevents CircRNA Cyclization in Hepatocellular Carcinoma
by: Ying Huang, et al.
Published: (2023-08-01) -
A Network Landscape of HPVOPC Reveals Methylation Alterations as Significant Drivers of Gene Expression via an Immune-Mediated GPCR Signal
by: Jesse R. Qualliotine, et al.
Published: (2023-09-01) -
Formation of nuclear CPSF6/CPSF5 biomolecular condensates upon HIV-1 entry into the nucleus is important for productive infection
by: Charlotte Luchsinger, et al.
Published: (2023-07-01)